Insiders · Profile

Quinn Anthony G.

President & CEO at Spyre Therapeutics. Filing since 12 Apr 2016. CIK 0001532219

Company

Date

Role

Action

Shares

Amount

Of holding

SYRE Spyre Therapeutics, Inc.

16 Mar 2022

President & CEO

Bought

80,079

$187.71K

17.0%

SYRE Spyre Therapeutics, Inc.

15 Mar 2022

President & CEO

Bought

42,417

$78.94K

9.8%

SYRE Spyre Therapeutics, Inc.

14 Mar 2022

President & CEO

Bought

67,472

$130.22K

18.6%

SYRE Spyre Therapeutics, Inc.

11 Mar 2022

President & CEO

Bought

34,777

$71.78K

10.6%

SYRE Spyre Therapeutics, Inc.

10 Dec 2021

President & CEO

Bought

10,526

$39.47K

3.3%

SYRE Spyre Therapeutics, Inc.

9 Dec 2021

President & CEO

Bought

43,108

$159.50K

15.7%

SYRE Spyre Therapeutics, Inc.

30 Apr 2020

President & CEO

Bought

165,000

$783.75K

44.2%

SYRE Spyre Therapeutics, Inc.

14 Jun 2019

President & CEO

Bought

5,282

$32.91K

1.5%

SYRE Spyre Therapeutics, Inc.

13 Jun 2019

President & CEO

Bought

14,406

$88.84K

4.3%

SYRE Spyre Therapeutics, Inc.

12 Jun 2019

President & CEO

Bought

12,217

$74.70K

3.8%

SYRE Spyre Therapeutics, Inc.

22 May 2019

President & CEO

Bought

3,809

$26.13K

1.2%

SYRE Spyre Therapeutics, Inc.

21 May 2019

President & CEO

Bought

13,794

$94.98K

4.5%

SYRE Spyre Therapeutics, Inc.

20 May 2019

President & CEO

Bought

8,989

$58.92K

3.0%

SYRE Spyre Therapeutics, Inc.

17 May 2019

President & CEO

Bought

6,218

$41.34K

2.2%

SYRE Spyre Therapeutics, Inc.

16 May 2019

President & CEO

Bought

5,520

$37.69K

1.9%

SYRE Spyre Therapeutics, Inc.

15 May 2019

President & CEO

Bought

6,256

$42.27K

2.3%

SYRE Spyre Therapeutics, Inc.

15 Feb 2019

President & CEO

Bought

719

$5.10K

0.3%

SYRE Spyre Therapeutics, Inc.

15 Aug 2018

President & CEO

Bought

994

$9.08K

1.0%

SYRE Spyre Therapeutics, Inc.

15 Feb 2018

President & CEO

Bought

2,000

$12.04K

2.2%

SYRE Spyre Therapeutics, Inc.

8 Dec 2017

Interim CEO

Bought

600

$3.04K

1.7%

SYRE Spyre Therapeutics, Inc.

7 Dec 2017

Interim CEO

Bought

2,800

$13.97K

8.7%

SYRE Spyre Therapeutics, Inc.

6 Dec 2017

Interim CEO

Bought

4,888

$24.07K

18.0%

SYRE Spyre Therapeutics, Inc.

5 Dec 2017

Director

Bought

5,065

$24.98K

23.0%

SYRE Spyre Therapeutics, Inc.

4 Dec 2017

Director

Bought

7,956

$39.62K

56.4%

SYRE Spyre Therapeutics, Inc.

1 Dec 2017

Director

Bought

4,100

$18.58K

41.0%

SYRE Spyre Therapeutics, Inc.

12 Apr 2016

Director

Bought

10,000

$100.00K

opened

26 decisions on file.